Startup focused on the research and development of innovative technologies in oncology and women’s health. Its two main products under development are a test to evaluate chemoresistance of hematological, breast, and ovarian tumors, and an auto-collector associated with a test for cervical cancer screening. It has 19 patent applications in total.
BUSINESS MODEL: Licensing of technology to pharmaceutical and partner companies and/or co-development, as well as B2B and B2C.
STAGE: Commercial approval
For further information, please contact us.
Back to Investors page